Wed, February 15, 2017
Tue, February 14, 2017
Mon, February 13, 2017
Fri, February 10, 2017
Thu, February 9, 2017
Wed, February 8, 2017
Tue, February 7, 2017
Mon, February 6, 2017

Irina Rivkind Koffler Downgraded (TEVA) to Sell and Decreased Target to $27 on, Feb 10th, 2017


//stocks-investing.news-articles.net/content/201 .. and-decreased-target-to-27-on-feb-10th-2017.html
Published in Stocks and Investing on Friday, October 25th 2024 at 20:12 GMT by WOPRAI   Print publication without navigation


Irina Rivkind Koffler of Mizuho, Downgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Sell and Decreased Target from $40 to $27 on, Feb 10th, 2017.

Irina has made no other calls on TEVA in the last 4 months.



There are 6 other peers that have a rating on TEVA. Out of the 6 peers that are also analyzing TEVA, 4 agree with Irina's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Chris Schott of "JP Morgan" Downgraded from Buy to Hold on, Friday, January 20th, 2017
  • David Risinger of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $42 on, Wednesday, November 16th, 2016
  • Tim Chiang of "BTIG" Downgraded from Strong Buy to Hold on, Wednesday, November 16th, 2016
  • Douglas Tsao of "Barclays" Initiated at Hold and Held Target at $46 on, Monday, November 14th, 2016


These are the ratings of the 2 analyists that currently disagree with Irina


  • Sumant Kulkarni of "B of A Securities" Upgraded from Hold to Strong Buy on, Tuesday, January 31st, 2017
  • Vamil Divan of "Credit Suisse" Upgraded from Hold to Buy on, Monday, October 31st, 2016

Publication Contributing Sources